Gerald Tegha

QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial

Kelly E. Dooley, Susan L. Rosenkranz, Francesca Conradie et al. · The Lancet Infectious Diseases · 2021 · 124 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study

Jared M. Baeten, Thesla Palanee‐Phillips, Nyaradzo Mgodi et al. · The Lancet HIV · 2021 · 111 citations · Full text

Medicine, Infectious Diseases, Preventive Medicine +16

Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial

Denise J. Jamieson, Charles S. Chasela, Michael G. Hudgens et al. · The Lancet · 2012 · 99 citations

Public Health, Maternal Health, Pediatrics +16

Maternal or Infant Antiretroviral Drugs to Reduce HIV-1 Transmission

C.S. Chasela, Michael G. Hudgens, Denise J. Jamieson et al. · Obstetric Anesthesia Digest · 2011 · 88 citations

Medicine, Maternal Health, Obstetrics +8

Prevention of HIV-1 Infection with Early Antiretroviral Therapy for the HPTN 052 Study Team*

Myron S. Cohen, Ying Qing Chen, Marybeth McCauley et al. · 2011 · 86 citations

Public Health, Infectious Diseases, Preventive Medicine +16